Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Meningioma 2Prostatic Neoplasms 1Neuroblastoma 1Ganglioneuroma 1Ganglioneuroblastoma 1Breast Neoplasms 1

Interventions

Cyclophosphamide 13Temozolomide 10Magnetic Resonance Spectroscopy 10dinutuximab 8X-Rays 8Specimen Handling 8Irinotecan 8Biopsy 8Phantoms, Imaging 7Topotecan 6Nuclear Medicine Department, Hospital 6fludarabine 5Vincristine 53-Iodobenzylguanidine 5fludarabine phosphate 4Granulocyte-Macrophage Colony-Stimulating Factor 4Etoposide 4tipifarnib 3sargramostim 3Radiotherapy 3Melphalan 3Isotretinoin 3Filgrastim 3Doxorubicin 3Carboplatin 3ulixertinib 2tazemetostat 2selpercatinib 2saponin QA-21V1 2pembrolizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroblastoma × Ga(III)-DOTATOC × 90 days × Clear all
NCT04040088 2026-03-31

An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine Tumors

Mayo Clinic

Phase EARLY_PHASE1 Active not recruiting
20 enrolled
CNS

Ganglioneuroma, Neuroblastoma, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡